SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-24-011229
Filing Date
2024-07-30
Accepted
2024-07-30 21:01:55
Documents
1
Period of Report
2024-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp2015709_4-venker.html 4  
1 FORM 4 dp2015709_4-venker.xml 4 6164
  Complete submission text file 0000950103-24-011229.txt   7637
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ROIVANT SCIENCES, INC. 320 WEST 37TH STREET, 6TH FLOOR NEW YORK NY 10018
Business Address
Venker Eric (Reporting) CIK: 0001801917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 241159590